Beta2-agonist tolerance and exercise-induced bronchospasm. - Test2 - elhamkhani - TriplyDB

Beta2-agonist tolerance and exercise-induced bronchospasm.

Beta2-agonist tolerance and exercise-induced bronchospasm.

http://www.wikidata.org/entity/Q43961067

about

Beta₂-agonists for exercise-induced asthma Beta-2 agonists for exercise induced asthma Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction Exercise-induced bronchoconstriction: pathogenesis National Athletic Trainers' Association position statement: management of asthma in athletes.Cromoglycate, reproterol, or both--what's best for exercise-induced asthma?Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction.Exercise-induced asthma: critical analysis of the protective role of montelukast Asthma, airway biology, and nasal disorders in AJRCCM 2002.Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials Management of exercise-induced bronchospasm in children: the role of leukotriene antagonists.Single-dose agents in the prevention of exercise-induced asthma: a descriptive review.Dietary polyunsaturated fatty acids in asthma- and exercise-induced bronchoconstriction.Bidirectional Counterregulation of Human Lung Mast Cell and Airway Smooth Muscle β2 Adrenoceptors.An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm.Section 2. Exercise-Induced Bronchospasm: Albuterol versus Montelukast: Highlights of the Asthma Summit 2009: Beyond the Guidelines A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes Exercise-induced bronchospasm in children.Exercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment.Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.Pre-Exercise Hyperpnea Attenuates Exercise-Induced Bronchoconstriction Without Affecting Performance.Challenges in the management of exercise-induced asthma.Treatment options for the management of exercise-induced asthma and bronchoconstriction.Asthma in elite athletes: pathogenesis, diagnosis, differential diagnoses, and treatment.Mechanisms and management of exercise-induced asthma in elite athletes.Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities.Oral beta2-agonist use by preschool children with asthma in East and Central Harlem, New York.Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment.Exercise-induced wheeze: Fraction of exhaled nitric oxide-directed management.Effect of fish oil-derived omega-3 polyunsaturated Fatty Acid supplementation on exercise-induced bronchoconstriction and immune function in athletes.Effect of terbutaline on hyperpnoea-induced bronchoconstriction and urinary club cell protein 16 in athletes.Cardiorespiratory screening in elite endurance sports athletes: the Quebec study.Asthma medication is increasingly prescribed for finnish olympic athletes--for a reason?An unusual case of sudden unexpected death: postmortem investigation and biomechanical analysis of the cervical spine.Pilot study: The effect of reducing treatment on exercise induced bronchoconstriction.

P2860

Q24197597-A54CA698-4EB8-4DA9-80A0-C59E08643681 Q24240704-A42E5B2B-2242-41CB-9C3B-F4CDFA467A5D Q24250226-18817C98-51B2-4206-8EE4-7B5270A37758 Q28289889-230008E3-56B9-466E-A2DC-6C118E994D8D Q28305092-35AD8295-5F9D-467D-AEBE-17387A69381F Q28769235-065F3F59-EF4F-4BE1-99DB-35FB8095B28F Q34242972-B986CBE3-52C5-4284-BED9-BB6F23BCA2BA Q34375152-E2A84BA3-1B73-4893-B9C1-A2D516D2D900 Q34623842-0B518B8F-E4B9-4C47-B55D-6359D7DAB025 Q35055447-1EF4798E-DD56-4BB1-A0BF-A8EEFCD7799F Q35677555-EFFC1A14-C688-4220-B41F-2B9A72ABD265 Q35790726-0C40BE2B-2242-4EF5-B256-BF8221E6A888 Q36013683-DC8EA085-13F1-41CF-8AF4-CACC478E09B8 Q36208750-B9686EF6-7BCA-4E15-9AD3-0E24F93FB06F Q36389176-BEB86D4C-0746-468C-A3BB-A8D60353269E Q36693149-FDE33A3C-186B-475E-8001-109545FC0DCC Q36834710-A0328518-45F0-40BF-8353-A1A2D33B44D4 Q36973812-9C201BAD-15C3-49C2-9AF4-9BBF58029D8C Q37106317-341944CE-F5C3-4DF2-86AF-E6A5983E7208 Q37145976-70A77364-3963-410A-919B-23DA35EB8E99 Q37151236-EFF9D968-930D-4AF5-A5DC-0C16794956D1 Q37451869-67F7406C-CD6D-4447-A232-F58394CBE93D Q37754632-2B0623E7-2966-4947-BC86-68E1414533A0 Q37819748-D94BBC56-A0B3-4D69-855C-D3A7B5206911 Q37949858-E4D6F8C9-0183-4DE3-92B4-40A91BD938B3 Q38003696-61E32289-86A4-453F-A48F-55C34576A57D Q38120057-10968C7C-D3C9-4198-86FA-2FA424F565E7 Q39744100-236AD9BE-665B-4A3B-8E61-42AED613F950 Q42401081-B554C0D0-830A-47F8-B0C8-5CE95842BB84 Q43118743-C80DBE38-33E6-4730-AEEA-6580032057AB Q43202599-B66AEBCC-9853-46BA-983F-F3F534535F54 Q44478219-45D3EF6E-0009-442C-9A5F-28AC089EFF9F Q45165794-611DE18E-77E5-4BED-BACD-DD8521745ED2 Q47290992-28736B3D-DD12-4E7F-B471-84905CA6C20B Q51062612-057A848F-C2DD-448A-A560-41F63118CD04 Q54319323-7AC34FCB-B681-4FF2-903D-452E6CD4938D

P2860

Beta2-agonist tolerance and exercise-induced bronchospasm.

http://www.wikidata.org/entity/Q43961067

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Beta2-agonist tolerance and exercise-induced bronchospasm.

@en

Beta2-agonist tolerance and exercise-induced bronchospasm.

@nl

type

label

Beta2-agonist tolerance and exercise-induced bronchospasm.

@en

Beta2-agonist tolerance and exercise-induced bronchospasm.

@nl

prefLabel

Beta2-agonist tolerance and exercise-induced bronchospasm.

@en

Beta2-agonist tolerance and exercise-induced bronchospasm.

@nl

P1433

Q43961067-A4573DD5-3533-4DB1-A0B7-EED12AF917E0

P1476

Q43961067-A1468E25-F70B-4EA9-90B1-1E69D28D747A

P2093

Q43961067-5117263E-9410-49C7-A0B5-CF6B1C1ECD60

Q43961067-852067D8-3837-4D75-B355-6EBF0DAAF24B

Q43961067-97EACAB8-E641-4D41-A6A6-5268B98EA106

Q43961067-B1FB8A07-0782-4490-9632-BEAAABE3445F

Q43961067-C630A29B-ACDD-4B51-AB8E-600878EA28DC

Q43961067-FDA142CF-867A-4442-9F61-FCF74B9706EE

P2860

Q43961067-4A0E4574-CCB5-4892-8D77-D2C5F0F6506B

Q43961067-B2A1C537-8FDD-489F-91AB-4CB417C87465

Q43961067-DA1124FE-6697-4895-B145-DF2D00CC020E

Q43961067-F5E90223-6A5F-48E7-AE44-70C7FFAD46D7

Q43961067-F7CE1AF4-3B85-4883-A1D9-A3361072FEDB

P304

Q43961067-D2CD8EB5-C9F1-4743-ABC5-97B188C2B3A1

P31

Q43961067-2546A160-C277-4102-AED6-01EF21220144

P356

Q43961067-F44A05B3-A8D7-4F76-828A-25F7B21D07C5

P407

Q43961067-04AACCE8-F604-477B-84C2-72AB2ADB70E5

P433

Q43961067-CDC1FED9-3372-469A-BFC2-FA4BFAFC3B1D

P478

Q43961067-AFB7DE65-DAE5-4AE3-8978-2E935E83C003

P577

Q43961067-90B9EEA3-8079-410C-88E4-B3A77CBB5A23

P698

Q43961067-85E3F1A4-69ED-4D6D-9070-26E01DA058FB

P921

Q43961067-8B4D4A75-06DB-46CC-BE5F-519DD2B1BD03

P356

AJRCCM.165.8.200111-091BC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Beta2-agonist tolerance and exercise-induced bronchospasm.

@en

P2093

Dennis Kamada

http://www.w3.org/2001/XMLSchema#string

Fredrick E Hargreave

http://www.w3.org/2001/XMLSchema#string

Mark D Inman

http://www.w3.org/2001/XMLSchema#string

Padmaja Subbarao

http://www.w3.org/2001/XMLSchema#string

Richard M Watson

http://www.w3.org/2001/XMLSchema#string

Robert J Hancox

http://www.w3.org/2001/XMLSchema#string

P2860

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

Functional antagonism: tolerance produced by inhaled beta 2 agonists

Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

P304

1068-1070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.165.8.200111-091BC

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11956046

http://www.w3.org/2001/XMLSchema#string

P921